That's a great call out. I do think this company fortunately and...

That's a great call out. I do think this company fortunately and unfortunately is a take over target of several large medical device companies. It would make a seriously compelling bolt on acquisition to the likes of Stryker or Zimmer Biomet. The product compliments medical device surigies and would be a terrific way to boost revenue per rap calling on existing surgeons. With the higher margin in the product, they would just incorporate into the product portfolio.

I think if they land around the 35Mil AUD mark in sales and become profitable, someone will try and snatch this up for <500Mil.

the unfortunate reality is biofilm infections is a major issue that is only really solved with Next Science technology/patents, and would be worth 2Bil in a couple years with its current growth rate.

It boils down to this upcoming half year report and if growth is there and continued commitment to profitability I think this should take off.